Correlation between interleukin-10 and in situ necrosis and fibrosis suggests a role for interleukin-10 in the resolution of the granulomatous response of tuberculous pleurisy patients

被引:6
作者
Barbosa, Theolis
Arruda, Sergio
Chalhoub, Marcelo
Oliveira, Fabiano
Melo, Jose F., Jr.
Fidelis, Ramon
Neto, Antonio N.
Barbosa, Aryon A., Jr.
Barral-Netto, Manoel
机构
[1] Fiocruz MS, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil
[2] Fdn Baiana Para & Desenvolvimento Ciencias, BR-40290000 Salvador, BA, Brazil
[3] Hosp Octavio Mangabeira, BR-40320350 Salvador, BA, Brazil
[4] Univ Fed Bahia, Fac Med, BR-40110100 Salvador, BA, Brazil
关键词
tuberculosis; pleural; disease progression; cytokines; pathology;
D O I
10.1016/j.micinf.2005.10.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to identify mediators involved in immune-mediated disease regression, the pleural cytokine and histopathological profile was evaluated in tuberculous pleurisy patients with varied disease duration and clinical presentation, previous to chemotherapy. Interleukin (IL)-10, interferon (IFN)-gamma and tumor necrosis factor (TNF) levels in pleural fluids were shown to decrease with disease time. IL-10 was positively correlated with IFN-gamma, TNF and necrosis area in pleural sections. To parallel these findings with disease regression, individuals showing fever, anorexia, and progressive exudate in the pleural cavity (active disease) were compared with patients without symptoms and with a decrease in exudate volume (regressive disease). IFN-gamma and TNF levels were lower in regressive disease, as well as reduced necrosis area in pleural sections. Our results indicate that tissue destruction and a prominent Th1 response mark the early phase of tuberculous pleurisy and suggest that down-modulation of this response, with the possible participation of IL-10, is associated with disease resolution. (c) 2006 Elsevier SAS. All rights reserved.
引用
收藏
页码:889 / 897
页数:9
相关论文
共 36 条
[11]   Levels of interleukin-8 in tuberculous pleurisy and the profile of immunocompetent cells in pleural and peripheral compartments [J].
Dlugovitzky, D ;
Rateni, L ;
TorresMorales, A ;
RuizSilva, J ;
Pinesky, R ;
Canosa, B ;
Molteni, O ;
Bottasso, O .
IMMUNOLOGY LETTERS, 1997, 55 (01) :35-39
[12]   Regulation of the human immune response during tuberculosis [J].
Ellner, JJ .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (05) :469-475
[13]   Granuloma necrosis during Mycobacterium avium infection does not require tumor necrosis factor [J].
Flórido, M ;
Appelberg, R .
INFECTION AND IMMUNITY, 2004, 72 (10) :6139-6141
[14]   Immunological basis of the development of necrotic lesions following Mycobacterium avium infection [J].
Flórido, M ;
Cooper, AM ;
Appelberg, R .
IMMUNOLOGY, 2002, 106 (04) :590-601
[15]   Detection of in vitro interferon-γ and serum tumour necrosis factor-α in multidrug-resistant tuberculosis patients [J].
Fortes, A ;
Pereira, K ;
Antas, PRZ ;
Franken, CLMC ;
Dalcolmo, M ;
Ribeiro-Carvalho, MM ;
Cunha, KS ;
Geluk, A ;
Kritski, A ;
Kolk, A ;
Klatser, P ;
Sarno, EN ;
Ottenhoff, THM ;
Sampaio, EP .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 141 (03) :541-548
[16]   ELEVATED LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS IN TUBERCULOUS PLEURAL EFFUSIONS [J].
ITO, M ;
KOJIRO, N ;
SHIRASAKA, T ;
MORIWAKI, Y ;
TACHIBANA, I ;
KOKUBU, T .
CHEST, 1990, 97 (05) :1141-1143
[17]   RELATIONSHIP OF THE MANIFESTATIONS OF TUBERCULOSIS TO CD4 CELL COUNTS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
JONES, BE ;
YOUNG, SMM ;
ANTONISKIS, D ;
DAVIDSON, PT ;
KRAMER, F ;
BARNES, PF .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (05) :1292-1297
[18]   TUBERCULOUS PLEURISY - AN ACUTE ILLNESS [J].
LEVINE, H ;
SZANTO, PB ;
CUGELL, DW .
ARCHIVES OF INTERNAL MEDICINE, 1968, 122 (04) :329-&
[19]   Memory lymphocytes from tuberculous effusions: Purified protein derivative (PPD) stimulates accelerated activation marker expression and cell cycle progression [J].
Lukey, PT ;
Latouf, SE ;
Ress, SR .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (03) :412-418
[20]  
MAEDA J, 1993, CLIN EXP IMMUNOL, V92, P32